$60,000 of HEALTHPEAK PROPERTIES INC. FKA PHYSICIANS REALTY TRUST lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"monitor legislation affecting real estate investment trusts oppose legislation prohibiting REITs ownership of healthcare property; monitor BioSecure legislation oppose adoption of Corporate SALT provisions monitor legislation affecting site neutral cuts in Medicare"
You can find more data on corporate lobbying on Quiver Quantitative.
DOC Congressional Stock Trading
Members of Congress have traded $DOC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
DOC Insider Trading Activity
DOC insiders have traded $DOC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DOC stock by insiders over the last 6 months:
- SCOTT R BOHN (CDO and Head of Lab) sold 10,989 shares for an estimated $213,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
DOC Hedge Fund Activity
We have seen 359 institutional investors add shares of DOC stock to their portfolio, and 268 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRINCIPAL FINANCIAL GROUP INC removed 7,916,128 shares (-29.7%) from their portfolio in Q1 2026, for an estimated $130,061,983
- BANK OF NEW YORK MELLON CORP added 5,815,189 shares (+60.3%) to their portfolio in Q1 2026, for an estimated $95,543,555
- ALYESKA INVESTMENT GROUP, L.P. added 5,616,667 shares (+inf%) to their portfolio in Q1 2026, for an estimated $92,281,838
- GEODE CAPITAL MANAGEMENT, LLC added 4,866,845 shares (+24.9%) to their portfolio in Q1 2026, for an estimated $79,962,263
- CITADEL ADVISORS LLC removed 4,510,650 shares (-95.9%) from their portfolio in Q1 2026, for an estimated $74,109,979
- FRANKLIN RESOURCES INC added 4,226,342 shares (+1487.1%) to their portfolio in Q1 2026, for an estimated $69,438,799
- DEUTSCHE BANK AG\ added 3,260,399 shares (+87.6%) to their portfolio in Q1 2026, for an estimated $53,568,355
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DOC Analyst Ratings
Wall Street analysts have issued reports on $DOC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 05/22/2026
To track analyst ratings and price targets for DOC, check out Quiver Quantitative's $DOC forecast page.
DOC Price Targets
Multiple analysts have issued price targets for $DOC recently. We have seen 11 analysts offer price targets for $DOC in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Michael Mueller from JP Morgan set a target price of $21.0 on 06/24/2026
- Juan Sanabria from BMO Capital set a target price of $24.0 on 06/15/2026
- Richard Hill from Morgan Stanley set a target price of $22.0 on 06/11/2026
- John Kilichowski from Wells Fargo set a target price of $20.0 on 06/01/2026
- Nicholas Yulico from Scotiabank set a target price of $21.0 on 05/27/2026
- Michael Carroll from RBC Capital set a target price of $21.0 on 05/14/2026
- An analyst from UBS set a target price of $19.0 on 05/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
